Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | METAP2 | P50579 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | AKT2 | P31751 | 1/20 | 0.41 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2170740 | 0.91 | KMT2A (0.54) | NPC1RAB9AMETAP2KMT2AMEN1 | |
| SCHEMBL2172656 | 0.78 | ATM (0.57) | METAP2KMT2AMEN1L3MBTL1 | |
| SCHEMBL2170887 | 0.77 | ATM (0.52) | METAP2KMT2AMEN1ALDH1A1TP53 | |
| SCHEMBL1346681 | 0.76 | NPC1 (0.63) | NPC1RAB9AMETAP2KMT2AMEN1 | |
| SCHEMBL4726588 | 0.75 | RAB9A (0.46) | NPC1RAB9AMETAP2KMT2AMEN1 | |
| SCHEMBL7917175 | 0.73 | ATM (0.53) | METAP2ALDH1A1HTT | |
| SCHEMBL4794131 | 0.72 | SMN1; SMN2 (0.41) | NPC1RAB9APOLBALDH1A1L3MBTL1 | |
| SCHEMBL2173199 | 0.72 | ATM (0.52) | NPC1RAB9AMETAP2KMT2APOLB | |
| SCHEMBL7924596 | 0.72 | TACR1 (0.49) | — | |
| SCHEMBL2467978 | 0.72 | METAP2 (0.47) | NPC1RAB9AMETAP2KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2346848-B1 | QUINAZOLINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS | HOFFMANN LA ROCHE (CH) | 2013-02-27 | — | — | EP | disclosed |